Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2019

01-11-2019 | ST-Segment Elevation Myocardial Infarction

MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort

Authors: Ying X. Gue, Natasha Corballis, Alisdair Ryding, Juan Carlos Kaski, Diana A. Gorog

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2019

Login to get access

Abstract

Historical data indicate that approximately 10% of acute coronary syndrome patients have no obstructive coronary artery disease (CAD) but contemporary incidence of non-obstructed coronary arteries in ST-segment elevation myocardial infarction (STEMI) is not clear. We aimed both to identify the contemporary incidence of MI without obstructive CAD (MINOCA)—using the ESC definition—and assess clinical outcomes. We assessed consecutive unselected STEMI patients presenting to the cardiac catheterisation laboratory with a view to undergoing primary percutaneous coronary intervention (PPCI). MINOCA was defined according to ESC criteria. Electronic patient records, blood results, angiographic and echocardiographic data were interrogated to determine final diagnosis, as well as 30-day and 1-year mortality rate. Of 2521 patients with full electronic dataset, 2158 (85.6%) underwent PPCI for obstructive CAD (angiographic stenosis > 70%). A further 167 (6.6%) with obstructive CAD were treated medically or surgically. The remaining 196 (7.8%) patients had absence of obstructive CAD at angiography, of whom 167 had no stenosis (< 30%) and 29 had mild coronary atheroma (stenosis > 30% but < 50%). A total of 110 (4.4%) patients met diagnostic criteria for MINOCA. All-cause mortality at 30-days and 1-year were 3.6% and 4.5%, respectively. In our cohort, 1 in 20 patients presenting with STEMI had MINOCA. This is the first description of the relatively high incidence of MINOCA in a STEMI cohort using current ESC definition and diagnostic criteria and could help power future trials in this area. Mortality rate was relatively high in our study and similar to that in large meta-analyses.
Literature
1.
go back to reference DeWood MA, Spores J, Notske R et al (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897–902CrossRef DeWood MA, Spores J, Notske R et al (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897–902CrossRef
2.
go back to reference DeWood MA, Stifter WF, Simpson CS et al (1986) Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 315:417–423CrossRef DeWood MA, Stifter WF, Simpson CS et al (1986) Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 315:417–423CrossRef
3.
go back to reference Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39:119–177CrossRef Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39:119–177CrossRef
4.
go back to reference Pasupathy S, Air T, Dreyer RP et al (2015) Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131:861–870CrossRef Pasupathy S, Air T, Dreyer RP et al (2015) Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131:861–870CrossRef
6.
go back to reference Gehrie ER, Reynolds HR, Chen AY et al (2009) Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early. Am Heart J 158:688–694CrossRef Gehrie ER, Reynolds HR, Chen AY et al (2009) Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early. Am Heart J 158:688–694CrossRef
7.
go back to reference Larsen AI, Galbraith PD, Ghali WA et al (2005) Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 95:261–263CrossRef Larsen AI, Galbraith PD, Ghali WA et al (2005) Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 95:261–263CrossRef
8.
go back to reference Lindahl B, Baron T, Erlinge D et al (2017) Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease clinical perspective. Circulation 135:1481–1489CrossRef Lindahl B, Baron T, Erlinge D et al (2017) Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease clinical perspective. Circulation 135:1481–1489CrossRef
9.
go back to reference Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39:2032–2046CrossRef Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39:2032–2046CrossRef
11.
go back to reference Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J 39:2047–2062CrossRef Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J 39:2047–2062CrossRef
12.
go back to reference Prasad A, Dangas G, Srinivasan M et al (2014) Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial. Catheter Cardiovasc Interv 83:343–348CrossRef Prasad A, Dangas G, Srinivasan M et al (2014) Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial. Catheter Cardiovasc Interv 83:343–348CrossRef
13.
go back to reference Widimsky P, Stellova B, Groch L et al (2006) Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. Can J Cardiol 22:1147–1152CrossRef Widimsky P, Stellova B, Groch L et al (2006) Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. Can J Cardiol 22:1147–1152CrossRef
14.
go back to reference Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938CrossRef Templin C, Ghadri JR, Diekmann J et al (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938CrossRef
15.
go back to reference Ghadri JR, Kato K, Cammann VL et al (2018) Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 72:874–882CrossRef Ghadri JR, Kato K, Cammann VL et al (2018) Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 72:874–882CrossRef
16.
go back to reference Hjort M, Lindahl B, Baron T, Jernberg T, Tornvall P, Eggers KM (2018) Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries. Am Heart J 200:60–66CrossRef Hjort M, Lindahl B, Baron T, Jernberg T, Tornvall P, Eggers KM (2018) Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries. Am Heart J 200:60–66CrossRef
17.
go back to reference Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, Brass N, Armstrong PW, Kaul P (2018) Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol 264:12–17CrossRef Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, Brass N, Armstrong PW, Kaul P (2018) Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol 264:12–17CrossRef
18.
go back to reference Tornvall P, Collste O, Ehrenborg E et al (2016) A case-control study of risk markers and mortality in Takotsubo stress cardiomyopathy. J Am Coll Cardiol 67:1931–1936CrossRef Tornvall P, Collste O, Ehrenborg E et al (2016) A case-control study of risk markers and mortality in Takotsubo stress cardiomyopathy. J Am Coll Cardiol 67:1931–1936CrossRef
19.
go back to reference Reynolds HR, Srichai MB, Iqbal SN et al (2011) Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 124:1414–1425CrossRef Reynolds HR, Srichai MB, Iqbal SN et al (2011) Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 124:1414–1425CrossRef
20.
go back to reference Niccoli G, Scalone G, Crea F (2015) Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J 36:475–481CrossRef Niccoli G, Scalone G, Crea F (2015) Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J 36:475–481CrossRef
21.
go back to reference Ong P, Athanasiadis A, Hill S et al (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome. J Am Coll Cardiol 52:523–527CrossRef Ong P, Athanasiadis A, Hill S et al (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome. J Am Coll Cardiol 52:523–527CrossRef
22.
go back to reference Beltrame JF, Crea F, Kaski JC et al (2015) International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:ehv351CrossRef Beltrame JF, Crea F, Kaski JC et al (2015) International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:ehv351CrossRef
23.
go back to reference Montone RA, Niccoli G, Fracassi F et al (2017) Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 39:91–98 Montone RA, Niccoli G, Fracassi F et al (2017) Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 39:91–98
24.
go back to reference Kaski JC (2018) Provocative tests for coronary artery spasm in MINOCA: necessary and safe? Eur Heart J 39:99–101CrossRef Kaski JC (2018) Provocative tests for coronary artery spasm in MINOCA: necessary and safe? Eur Heart J 39:99–101CrossRef
Metadata
Title
MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort
Authors
Ying X. Gue
Natasha Corballis
Alisdair Ryding
Juan Carlos Kaski
Diana A. Gorog
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2019
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01919-5

Other articles of this Issue 4/2019

Journal of Thrombosis and Thrombolysis 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.